Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.
Financial Results:
- Orchid Pharma Ltd reported Revenues for Q2FY24 of ₹199.00 Crores up from ₹165.00 Crore year on year, a rise of 20.61%.
- Total Expenses for Q2FY24 of ₹187.00 Crores up from ₹174.00 Crores year on year, a rise of 7.47%.
- Consolidated Net Profit of ₹20.00 Crores from -₹5.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹3.90, from -₹1.32 in the same quarter of the previous year.